In this lively debate pertaining to all things multiple myeloma, Chadi hosts three guests with varying positions and viewpoints: Vincent Rajkumar, MD, Mayo Clinic; Manni Mohyuddin, MD, Huntsman Cancer Institute; and Cindy Chmielewski, patient research advocate. The group discusses the burning unanswered questions in multiple myeloma research and treatment – including problems related to clinical trial funding and design, control arms and “bad” trials, global disparities and drug access, standard-of-care changes during the course of a trial, and many more intricate dilemmas impacting the multiple myeloma world today.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
